Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.

A Phoenix doctor weighs in on the potential impact of FDA plans to limit COVID booster access to high-risk groups, raising ...

The FDA’s new policy limits COVID-19 vaccine eligibility to older adults and high-risk groups, excluding millions from ...

Under the new FDA guidelines, only people 65 and older and others with one or more health risk factors will be able to receive COVID-19 vaccinations. People considered healthy and under the age of 65 ...

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

The revised version of the vaccine, marketed as Spikevax, follows FDA guidance recommending that this year’s shots target ...

An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...

The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine ...

In a major and controversial policy shift, the FDA announced in a New England Journal of Medicine article that updated ...

FDA's new COVID-19 vaccine policy may restrict low-risk individuals' access, pending clinical trials to prove benefits.

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.